Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel with or without Carboplatin in Elderly Metastatic Breast Cancer
NCT00025688Phase 3Unknown
- Sponsor
- Theradex Oncology
- Start
- Jan 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of carboplatin in breast cancer, sponsored by Theradex Oncology. Primary endpoint: Objective Response Rate. Status: unknown.
02
Drugs
carboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00025688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025688.